Editorial: Novel methods and technologies for the evaluation of drug outcomes and policies.

Adamson, Blythe; Makady, Amr; Sarri, Grammati; Mohamed, Omneya; Babar, Zaheer; Dawoud, Dalia M

Adamson, Blythe; Makady, Amr; Sarri, Grammati; Mohamed, Omneya; Babar, Zaheer; Dawoud, Dalia M.

Afiliación

Adamson B; Flatiron Health, New York, NY, United States.
Makady A; The Comparative Health Outcomes, Policy and Economics (CHOICE) Institute, University of Washington, Seattle, WA, United States.
Sarri G; Janssen-Cilag B.V., Breda, Netherlands.
Mohamed O; Cytel, London, United Kingdom.
Babar Z; Baxter AG Scientific Office, Dubai, United Arab Emirates.
Dawoud DM; Department of Pharmacy, University of Huddersfield, Huddersfield, United Kingdom.

Front Pharmacol ; 15: 1396034, 2024.

Article en En | MEDLINE | ID: mdl-38698818

Palabras clave

HEOR; analytic; artificial intelligence; causal inference; health technology assessment (HTA); methods

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google